NCT00519025|CompletedDMC
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · UPMC
observational
360
1 country
1
Study Start
August 2007
Actual (reported)Primary Completion
June 2017
Actual (reported)Study Completion
June 2017
Actual (reported)This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2007
Actual (reported)August 17, 2007
Actual (reported)August 21, 2007
Actual (reported)June 2017
Actual (reported)June 2017
Actual (reported)linezolid resistance to staph aureus
Contact the study team to confirm eligibility.
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Brian Potoski, PharmD
University of Pittsburgh
360 participants (actual enrollment reported by the registry).
First Submitted
August 17, 2007
First Posted
August 21, 2007
Study Start
August 2007
Actual (reported)Primary Completion
June 2017
Actual (reported)Study Completion
June 2017
Actual (reported)Last Updated
June 12, 2018
Record last verified: 2018-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: